|
KMID : 1225720230150030395
|
|
Allergy, Asthma & Immunology Research : AAIR
2023 Volume.15 No. 3 p.395 ~ p.405
|
|
|
Clinical Characteristics of Post-COVID-19 Persistent Cough in the Omicron Era
|
|
Kang Yu-Ri
Huh Jin-Young
Oh Ji-Yoon
Lee Ji-Hyang
Lee Dae-Geun
Kwon Hyouk-Soo
Kim Tae-Bum
Choi Jae-Chol
Cho You-Sook
Kian Fan Chung
Park So-Young
Song Woo-Jung
|
|
|
Abstract
|
|
|
|
Cough is one of the most common symptoms of acute coronavirus disease 2019, but cough may persist for weeks or months. This study aimed to examine the clinical characteristics of patients with post-coronavirus disease (COVID) persistent cough in the Omicron era. We conducted a pooled analysis comparing 3 different groups: 1) a prospective cohort of post-COVID cough (> 3 weeks; n = 55), 2) a retrospective cohort of post-COVID cough (> 3 weeks; n = 66), and 3) a prospective cohort of non-COVID chronic cough (CC) (> 8 weeks; n = 100). Cough and health status was assessed using patient-reported outcomes (PROs). Outcomes, including PROs and systemic symptoms, were longitudinally evaluated in the prospective post-COVID cough registry participants receiving usual care. A total of 121 patients with post-COVID cough and 100 with non-COVID CC were studied. Baseline cough-specific PRO scores did not significantly differ between post-COVID cough and non-COVID CC groups. There were no significant differences in chest imaging abnormality or lung function between groups. However, the proportions of patients with fractional exhaled nitric oxide (FeNO) ≥ 25 ppb were 44.7% in those with post-COVID cough and 22.7% in those with non-COVID CC, which were significantly different. In longitudinal assessment of the post-COVID registry (n = 43), cough-specific PROs, such as cough severity or Leicester Cough Questionnaire (LCQ) scores, significantly improved between visits 1 and 2 (visit interval: median 35 [interquartile range, IQR: 23?58] days). In the LCQ score, 83.3% of the patients showed improvement (change ≥ +1.3), but 7.1% had worsened (≤ ?1.3). The number of systemic symptoms was median 4 (IQR: 2?7) at visit 1 but decreased to median 2 (IQR: 0?4) at visit 2. In summary, post-COVID persistent cough was similar in overall clinical characteristics to CC. Current cough guideline-based approaches may be effective in most patients with post-COVID cough. Measurement of FeNO levels may also be useful for cough management.
|
|
|
KEYWORD
|
|
|
Cough, COVID-19, asthma, Omicron era, cohort, longitudinal assessment, nitric oxide, post-COVID syndrome
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|
|